top of page

Search


Biotech Licensing Strategy: The Hidden Terms That Scare Investors
Most founders think a licensing agreement signals progress. “Look, someone validated our science. " “We secured IP.” “We have a partner.” But the uncomfortable truth is: 👉 Many early licensing agreements quietly undermine the next round, even when they were signed with the best intentions. You don’t see the red flags anymore because you’ve been living inside the deal. Investors, however? They see them instantly. 👉 And they start thinking: “Who really owns the asset?” “How

Attila Foris
Dec 15, 20253 min read
bottom of page
